These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12071237

  • 1. Propofol in rats: testing for nonlinear pharmacokinetics and modelling acute tolerance to EEG effects.
    Ihmsen H, Tzabazis A, Schywalsky M, Schwilden H.
    Eur J Anaesthesiol; 2002 Mar; 19(3):177-88. PubMed ID: 12071237
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats.
    Schywalsky M, Ihmsen H, Tzabazis A, Fechner J, Burak E, Vornov J, Schwilden H.
    Eur J Anaesthesiol; 2003 Mar; 20(3):182-90. PubMed ID: 12650488
    [Abstract] [Full Text] [Related]

  • 3. Physicochemical properties, pharmacokinetics, and pharmacodynamics of a reformulated microemulsion propofol in rats.
    Lee EH, Lee SH, Park DY, Ki KH, Lee EK, Lee DH, Noh GJ.
    Anesthesiology; 2008 Sep; 109(3):436-47. PubMed ID: 18719441
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion.
    Fechner J, Ihmsen H, Hatterscheid D, Jeleazcov C, Schiessl C, Vornov JJ, Schwilden H, Schüttler J.
    Anesthesiology; 2004 Sep; 101(3):626-39. PubMed ID: 15329587
    [Abstract] [Full Text] [Related]

  • 7. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N, Calvo R, Agrad FZ, Lukas JC, de la Fuente L, Suarez E.
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [Abstract] [Full Text] [Related]

  • 8. Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol.
    Cox EH, Knibbe CA, Koster VS, Langemeijer MW, Tukker EE, Lange R, Kuks PF, Langemeijer HJ, Lie-A-Huen L, Danhof M.
    Pharm Res; 1998 Mar; 15(3):442-8. PubMed ID: 9563075
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.
    Lee SH, Ghim JL, Song MH, Choi HG, Choi BM, Lee HM, Lee EK, Roh YJ, Noh GJ.
    Br J Pharmacol; 2009 Dec; 158(8):1982-95. PubMed ID: 19925493
    [Abstract] [Full Text] [Related]

  • 10. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
    Bienert A, Wiczling P, Zaba C, Zaba Z, Wolc A, Marciniak R, Grześkowiak E, Kusza K.
    Arzneimittelforschung; 2011 Dec; 61(10):545-52. PubMed ID: 22164962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
    Calvo R, Telletxea S, Leal N, Aguilera L, Suarez E, De La Fuente L, Martin-Suarez A, Lukas JC.
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictability of processed electroencephalography effects on the basis of pharmacokinetic-pharmacodynamic modeling during repeated propofol infusions in patients with extradural analgesia.
    Kuizenga K, Proost JH, Wierda JM, Kalkman CJ.
    Anesthesiology; 2001 Sep; 95(3):607-15. PubMed ID: 11575531
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bispectral index dynamics during propofol hypnosis is similar in red-haired and dark-haired subjects.
    Doufas AG, Orhan-Sungur M, Komatsu R, Lauber R, Akca O, Shafer SL, Sessler DI.
    Anesth Analg; 2013 Feb; 116(2):319-26. PubMed ID: 23302977
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.
    Dahaba AA, Xiao Z, Zhu X, Dong H, Xiong L, Rehak P, Zelzer S, Wang K, Reibnegger G.
    J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):145-161. PubMed ID: 32100175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.